Status:
RECRUITING
Expressive Writing for the Management of Stress in Cancer Survivors
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Hematopoietic and Lymphoid Cell Neoplasm
Malignant Solid Neoplasm
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This clinical trial evaluates the effect of expressive writing for the management of stress in cancer survivors. Cancer diagnosis and treatment are associated with increased stress in cancer survivors...
Detailed Description
PRIMARY OBJECTIVES: I. To evaluate the feasibility of the virtual study for cancer survivors. II. To preliminarily assess the impact of the intervention for cancer survivors. OUTLINE: Patients are r...
Eligibility Criteria
Inclusion
- At least 18 years old
- Have a diagnosis of cancer within the past 3 years
- Are able to speak and read in English
- Have access to a computer or smart phone with internet connection
- All disease sites and all cancer stages are eligible for enrollment
Exclusion
- Inability to provide informed consent
- Non-English speakers will be excluded because this is a feasibility study that will enroll only a limited number of participants
Key Trial Info
Start Date :
August 7 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2028
Estimated Enrollment :
414 Patients enrolled
Trial Details
Trial ID
NCT04776941
Start Date
August 7 2020
End Date
December 31 2028
Last Update
November 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
M D Anderson Cancer Center
Houston, Texas, United States, 77030